SPECIFIC AIMS: The administration of glutamatergic NMDA receptor (NMDAR) antagonists to human subjects elicits core

  • Published 2012

Abstract

The administration of glutamatergic NMDA receptor (NMDAR) antagonists to human subjects elicits core symptoms of schizophrenia, implicating hypofunction of NMDARs in the disease process. However, identifying sensitive periods and potential cell-types of NMDAR hypofunction has proven elusive. The first strong evidence that NMDAR hypofunction occurs in… (More)

Topics

4 Figures and Tables

Cite this paper

@inproceedings{2012SPECIFICAT, title={SPECIFIC AIMS: The administration of glutamatergic NMDA receptor (NMDAR) antagonists to human subjects elicits core}, author={}, year={2012} }